Amazon announces its acquisition of online pharmacy PillPack

By Catherine Sturman
Amazon has announced its decision acquire online pharmacy PillPack for just under $1bn. The online pharmacy is committed to driving exceptional customer...

Amazon has announced its decision acquire online pharmacy PillPack for just under $1bn. The online pharmacy is committed to driving exceptional customer services, particularly to those who take multiple daily prescriptions.

Delivering medications in pre-sorted dose packaging, coordinates refills and renewals, the company makes sure shipments are sent on time, and will open up further doors for Amazon to provide essential solutions, particularly to aging populations.

The news has been long feared by traditional pharmaceutical companies, and follows on from its work with the American Association of Retired Persons (AARP) and its partnership with JPMorgan and Berkshire Hathaway.

“PillPack’s visionary team has a combination of deep pharmacy experience and a focus on technology,” says Jeff Wilke, Amazon CEO Worldwide Consumer. a

“PillPack is meaningfully improving its customers’ lives, and we want to help them continue making it easy for people to save time, simplify their lives, and feel healthier. We’re excited to see what we can do together on behalf of customers over time.”

See also

The news is ramped up concerns across the industry and will provide rampant competition in lowering drug prices across the US, as well as enhance quality of care. Berkshire Hathaway’s CEO Warren Buffet has even described escalating healthcare costs as a ‘hungry tapeworm.’

“PillPack makes it simple for any customer to take the right medication at the right time, and feel healthier,” said TJ Parker, co-founder and CEO of PillPack. “Together with Amazon, we are eager to continue working with partners across the healthcare industry to help people throughout the US who can benefit from a better pharmacy experience.”

PillPack holds pharmacy licenses in all 50 states, has URAC and VIPPS accreditation, and is an in-network pharmacy with most PBMs, including major Medicare Part D plans. It has also built a proprietary set of software systems and tools.

Upon hearing the news, shares in major drug companies, Walgreens Boots Alliance, CVS and others plunged by 8.2% and 7.9% respectively in pre-market trading.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare